SCHEMBL4807734

SCHEMBL4807734

COc1ccc2c(c1)S(=O)(=O)N=C1CCCN12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.56
ALDH1A1 P00352 5/20 0.51
TDP1 Q9NUW8 2/20 0.49
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
KDM4E B2RXH2 2/20 0.44
HTT P42858 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5352406 0.80 KMT2A (0.56) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5357893 0.80 ALDH1A1 (0.45) KMT2AALDH1A1POLBMAPTKDM4E
SCHEMBL5352984 0.80 KMT2A (0.47) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL4806409 0.78 KMT2A (0.51) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5643991 0.78 KMT2A (0.51) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL4807666 0.77 GRIA2 (0.48) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5624476 0.77 ALDH1A1 (0.47) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5658946 0.77 KMT2A (0.50) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5628029 0.76 L3MBTL1 (0.55) KMT2AALDH1A1TDP1POLBMAPT
SCHEMBL5644923 0.76 ALDH1A1 (0.51) KMT2AALDH1A1TDP1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423034-B2 Benzothiazine and benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2008-09-09 US disclosed
US-20070249594-A1 Benzothiazine and benzothiadiazine compounds DESOS PATRICE 2007-10-25 US disclosed
US-7262189-B2 Benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVER (FR) 2007-08-28 US disclosed
US-7253161-B2 Benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2007-08-07 US disclosed
US-7253163-B2 Benzothiazine and benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-08-07 US disclosed
US-7253162-B2 Benzothiazine and benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-08-07 US disclosed
EP-1486503-B1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2006-11-02 EP disclosed
US-20050124606-A1 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2005-06-09 US disclosed
US-20050065146-A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2005-03-24 US disclosed
US-20040254371-A1 New benzothiazine and benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2004-12-16 US disclosed
US-20040254161-A1 New benzothiazine and benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2004-12-16 US disclosed
EP-1486503-A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2004-12-15 EP disclosed
EP-1486502-A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2004-12-15 EP disclosed
US-6635635-B2 5,5-dioxo-2,3,3a,4-tetrahydro-1 H-pyrrolo(2,1-c)(1,2,4)-benzothiadiazin-7-ol, for example; nervous system disorders; alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulators LES LABORATOIRES SERVIER (FR) 2003-10-21 US disclosed
US-20020037894-A1 Benzothiadiazine compounds ADIR ET COMPAGNIE (FR) 2002-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249594-A1 Benzothiazine and benzothiadiazine compounds GRIA4, GABRA4, GRIK4 KMT2A 467/4885ALDH1A1 505/4885TDP1 1599/4885
US-20040254371-A1 New benzothiazine and benzothiadiazine compounds NR4A1, NR4A3, NR4A2 KMT2A 583/4885ALDH1A1 1073/4885TDP1 2157/4885
US-20040254161-A1 New benzothiazine and benzothiadiazine compounds NR4A1, NR4A3, NR4A2 KMT2A 396/4885ALDH1A1 775/4885TDP1 1501/4885
US-20020037894-A1 Benzothiadiazine compounds HCAR1, GLRA1, HCAR2 KMT2A 987/4885ALDH1A1 239/4885TDP1 1563/4885
US-20050065146-A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same NR5A2, NR4A3, CBR3 KMT2A 2006/4885ALDH1A1 2038/4885TDP1 4225/4885
US-20050124606-A1 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same NR4A3, NR5A2, NR4A1 KMT2A 1039/4885ALDH1A1 2161/4885TDP1 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.